欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
中文摘要：
在欧盟国家．药品市场是受到最严厉管制的市场之一。通过价格管制、疗效一成本定价、利润控制、参考定价、国际参考定价、费用返还、费用分担、鼓励合理用药、非专利药政策等干预措施。政府力图实现控制药费支出．同时保障药品供应和公平性、保证药物质量和鼓励药品企业创新。欧盟国家在药品价格管理方面的多样性为我国制定相关政策提供了有益的参考。
英文摘要：
In most Europe Union （EU） countries, the pharmaceutical market is the most heavily regulatedone. Through different approaches of pharmaceutical pricing management, such as price control, cost-effectiveness pricing, profit control, reference pricing, international reference pricing, cost-sharing, payback, incentives for good prescribing practice and generics policy, authorities of EU countries try to control pharmaceutical expenditure, to secure, the availability, equality and safety to patients, and to encourage industry innovation. A variety of pharmaceutical pricing management in different EU countries can provide a useful reference to draw up policy in China.
同期刊论文项目
同项目期刊论文
Toward integrated and sustainable prevention against diabetes in rural China: study rationale and pr
Life events and chronic physical conditions among left-behind farmers in rural China a cross-section
Relationships between stressful life events and impaired fasting glucose among left-behind farmers i
Modeling Age-specific Cancer Incidences Using Logistic Growth Equations: Implications for Data Colle
Association of risk of gastric cancer and consumption of tobacco, alcohol and tea in the Chinese pop
Association between pancreatitis and subsequent risk of pancreatic cancer: a systematic review of ep
Effects of psycho-behavioral interventions on immune functioning in cancer patients: a systematic re
Assessment and model guided cancer screening promotion by village doctors in China: a randomized con
Psychosocial and Behavioral Interventions and Cancer Patient Survival Again: Hints of an Adjusted Me
期刊信息
位置：